Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation

Cancer Research

Volumn 67, Issue 24, 2007, Pages 11789-11797

  Germaniuk Kurowska, Aleksandra ^a,b   Nag, Alo ^a,b   Zhao, Xiangshan ^a,b,c   Dimri, Manjari ^a,b   Band, Hamid ^a,b,d   Band, Vimla ^a,b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; DNA DIRECTED DNA POLYMERASE ALPHA; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCEROL; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE GCN5; HISTONE ACETYLTRANSFERASE PCAF; LIGAND; PROTEIN ADA3; PROTEIN PS2; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SEDIMENTATION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CHROMATIN; COLLAGEN; DRUG COMBINATIONS; ESTROGENS; FEMALE; HISTONE ACETYLTRANSFERASES; HUMANS; LAMININ; PROTEOGLYCANS; RECEPTORS, ESTROGEN; RNA, NEOPLASM; TRANSCRIPTION FACTORS;

EID: 37549007650     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2721     Document Type: Article

References (40)

1. Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-65.
2. Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006;102:89-96.
3. Robinson-Rechavi M, Escriva Garcia H, Laudet V. The nuclear receptor superfamily. J Cell Sci 2003;116:585-6.
4. Singh RR, Kumar R. Steroid hormone receptor signaling in tumorigenesis. J Cell Biochem 2005;96:490-505.
5. Barnes CJ, Vadlamudi RK, Kumar R. Novel estrogen receptor coregulators and signaling molecules in human diseases. Cell Mol Life Sci 2004;61:281-91.
6. Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004;25:45-71.
7. Heery DM, Kalkhoven E, Hoare S, Parker MG. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997;387:733-6.
8. Needham M, Raines S, McPheat J, et al. Differential interaction of steroid hormone receptors with LXXLL motifs in SRC-1a depends on residues flanking the motif. J Steroid Biochem Mol Biol 2000;72:35-46.
9. Katzenellenbogen BS, Choi I, Delage-Mourroux R, et al. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 2000;74:279-85.
10. Marcus GA, Silverman N, Berger SL, Horiuchi J, Guarente L. Functional similarity and physical association between GCN5 and ADA2: putative transcriptional adaptors. EMBO J 1994;13:4807-15.
11. Horiuchi J, Silverman N, Marcus GA, Guarente L. ADA3, a putative transcriptional adaptor, consists of two separable domains and interacts with ADA2 and GCN5 in a trimeric complex. Mol Cell Biol 1995;15:1203-9.
12. vom Baur E, Harbers M, Um SJ, Benecke A, Chambon P, Losson R. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors. Genes Dev 1998;12:1278-89.
13. Zeng M, Kumar A, Meng G, et al. Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator. J Biol Chem 2002;277:45611-8.
14. Meng G, Zhao Y, Nag A, et al. Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation. J Biol Chem 2004;279:54230-40.
15. Kumar A, Zhao Y, Meng G, et al. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol Cell Biol 2002;22:5801-12.
16. Wang T, Kobayashi T, Takimoto R, et al. hADA3 is required for p53 activity. EMBO J 2001;20:6404-13.
17. Nag A, Germaniuk-Kurowska A, Dimri M, et al. An essential role of human Ada3 in p53 acetylation. J Biol Chem 2007;282:8812-20.
18. Shao W, Brown M. Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res 2004;6:39-52.
19. Marmorstein R. Structure of histone acetyltransferases. J Mol Biol 2001;311:433-44.
20. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003;30:256-68.
21. Dimri M, Naramura M, Duan L, et al. Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. Cancer Res 2007;67:4164-72.
22. Christova R, Oelgeschlager T. Association of human TFIID-promoter complexes with silenced mitotic chromatin in vivo. Nat Cell Biol 2002;4:79-82.
23. Eberharter A, Sterner DE, Schieltz D, et al. The ADA complex is a distinct histone acetyltransferase complex in Saccharomyces cerevisiae. Mol Cell Biol 1999;19:6621-31.
24. Ogryzko VV, Kotani T, Zhang X, et al. Histone-like TAFs within the PCAF histone acetylase complex. Cell 1998;94:35-44.
25. Dilworth FJ, Chambon P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 2001;20:3047-54.
26. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M. Positive cross-regulatory loop ties GATA-3 to estrogen receptor α expression in breast cancer. Cancer Res 2007;67:6477-83.
27. Nelson CM, Bissell MJ. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 2005;15:342-52.
28. Li T, Sotgia F, Vuolo MA, et al. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor α-positive status. Am J Pathol 2006;168:1998-2013.
29. Itoh M, Nelson CM, Myers CA, Bissell MJ. Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells. Cancer Res 2007;67:4759-66.
30. Ellis MJ, Rigden CE. Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current data. Curr Med Res Opin 2006;22:2479-87.
31. Liao L, Kuang SQ, Yuan Y, Gonzalez SM, O'Malley BW, Xu J. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. J Steroid Biochem Mol Biol 2002;83:3-14.
32. Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ, O'Malley BW. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 1998;279:1922-5.
33. Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 2003;17:1681-92.
34. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O'Malley BW. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci U S A 2000;97:6379-84.
35. List HJ, Lauritsen KJ, Reiter R, Powers C, Wellstein A, Riegel AT. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. J Biol Chem 2001;276:23763-8.
36. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000;103:843-52.
37. Saleh A, Lang V, Cook R, Brandl CJ. Identification of native complexes containing the yeast coactivator/ repressor proteins NGG1/ADA3 and ADA2. J Biol Chem 1997;272:5571-8.
38. Forsberg EC, Lam LT, Yang XJ, Nakatani Y, Bresnick EH. Human histone acetyltransferase GCN5 exists in a stable macromolecular complex lacking the adapter ADA2. Biochemistry 1997;36:15918-24.
39. Kusch T, Guelman S, Abmayr SM, Workman JL. Two Drosophila Ada2 homologues function in different multiprotein complexes. Mol Cell Biol 2003;23:3305-19.
40. Muratoglu S, Georgieva S, Papai G, et al. Two different Drosophila ADA2 homologues are present in distinct GCN5 histone acetyltransferase-containing complexes. Mol Cell Biol 2003;23:306-21.